Title:
【発明の名称】酵素等を抗体等に結合させるホモバイファンクショナル試薬
Document Type and Number:
Japanese Patent JP3360174
Kind Code:
B2
Abstract:
A coupling agent useful in conducting immunoassays, particularly assays for B12, is disclosed. The coupling agent has the formula Z and Z' can be the same or different and each is k, m and n are integers from 1 to 10, X is an alkylene group, a cycloalkylene group, an alkylcycloalkylene group, a bivalent aromatic group, or an aminoalkylene group, R and R' can be the same or different, and each is a substituted or unsubstituted aminoalkylene group having from 1 to 10 carbon atoms or a cycloalkylene or alkylcycloalkylene group having from 5 to 20 carbon atoms. Z and Z' are the same except that they can be the same or different when both are A method for purifying an aqueous intrinsic factor solution which contains R-protein is disclosed. The method involves adding to the intrinsic factor solution an amount of cobinamide sufficient to bind substantially all of the R-protein in the solution and an amount of an intrinsic factor affinity resin sufficient to bind the intrinsic factor in the solution, washing the bound cobinamide and the R-protein from the resin, eluting the intrinsic factor from the resin, and dialyzing the eluted intrinsic factor. The purified intrinsic factor can contain less than 0.004 percent cross reactivity with cobinamides, and at least 95 percent of the proteins in the purified material can bind cobalamins. A conjugate where microparticles and the purified intrinsic factor are conjugated by a moiety from one of the foregoing coupling agents is also disclosed, as is a kit for conducting an assay for cobalamins which includes the conjugate of microparticles and purified intrinsic factor. A method for conducting an assay for cobalamins, which method involves the use of the conjugate of microparticles and purified intrinsic factor is also disclosed.
More Like This:
Inventors:
Viennas, Christopher
Welch, christopher
Welch, christopher
Application Number:
JP51838191A
Publication Date:
December 24, 2002
Filing Date:
October 18, 1991
Export Citation:
Assignee:
Abbott Laboratories
International Classes:
C07C233/34; C07C243/28; C07C243/36; C07C275/14; C07D207/452; C07D207/46; C07D403/12; C07K1/113; C07K1/22; C07K14/00; C07K14/47; C07K17/06; C07K19/00; C12N11/06; G01N33/53; G01N33/532; G01N33/543; G01N33/547; G01N33/82; (IPC1-7): C07C243/28; C07D207/46; C07K17/06; G01N33/53; G01N33/547
Domestic Patent References:
| JP5123290A | ||||
| JP4228098A |
Other References:
Ａｐｐｌ．Ｂｉｏｃｈｅｍ．Ｂｉｏｔｅｃｈｎｏｌ．，（１９８５），Ｖｏｌ．１１，Ｎｏ．６，ｐ．４４５−４５６
Ｊ．Ｃｈｅｍ．Ｓｏｃ．，Ｃｈｅｍ．Ｃｏｍｍｕｎ．，（１９８６），ｐ．６５９−６６１
Ｊ．Ｃｏｏｒｄ．Ｃｈｅｍ．，（１９８６），Ｖｏｌ．１４，Ｎｏ．３，ｐ．２４１−２４８
Ｊ．Ｍｅｄ．Ｃｈｅｍ．，（１９８５），Ｖｏｌ．２８，Ｎｏ．９，ｐ．１１４０−１１４１
Ｊ．Ｃｈｅｍ．Ｓｏｃ．，Ｃｈｅｍ．Ｃｏｍｍｕｎ．，（１９８６），ｐ．６５９−６６１
Ｊ．Ｃｏｏｒｄ．Ｃｈｅｍ．，（１９８６），Ｖｏｌ．１４，Ｎｏ．３，ｐ．２４１−２４８
Ｊ．Ｍｅｄ．Ｃｈｅｍ．，（１９８５），Ｖｏｌ．２８，Ｎｏ．９，ｐ．１１４０−１１４１
Attorney, Agent or Firm:
Takehiko Saitoh